Lek Must First Make Sure It Grows, Its Chair Says
Ljubljana, 22 April - The generics Lek, which sold medicine worth US$ 183.1m in the January-to-March period, has to keep making efforts for its excellence and success, the new chair of the board maintains.
The rest of this news item is available to subscribers.
The news item consists of 1.300 characters (without spaces) or 268 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.